tacforius
teva b.v. - takrolimuusimonohydraatti - liver transplantation; kidney transplantation - immunosuppressantit - aivojen munuaisten tai maksan allograftin vastaanottajien profylaksi. allograftin hylkimisen hoito, joka on resistentti hoidossa muiden immunosuppressiivisten lääkevalmisteiden kanssa aikuisilla potilailla.
dailiport 0.5 mg depotkapseli, kova
sandoz a/s - tacrolimus monohydrate - depotkapseli, kova - 0.5 mg - takrolimuusi
dailiport 1 mg depotkapseli, kova
sandoz a/s - tacrolimus monohydrate - depotkapseli, kova - 1 mg - takrolimuusi
dailiport 2 mg depotkapseli, kova
sandoz a/s - tacrolimus monohydrate - depotkapseli, kova - 2 mg - takrolimuusi
dailiport 3 mg depotkapseli, kova
sandoz a/s - tacrolimus monohydrate - depotkapseli, kova - 3 mg - takrolimuusi
dailiport 5 mg depotkapseli, kova
sandoz a/s - tacrolimus monohydrate - depotkapseli, kova - 5 mg - takrolimuusi
idefirix
hansa biopharma ab - imlifidase - desensitization, immunologic; kidney transplantation - immunosuppressantit - idefirix is indicated for desensitisation treatment of highly sensitised adult kidney transplant patients with positive crossmatch against an available deceased donor. the use of idefirix should be reserved for patients unlikely to be transplanted under the available kidney allocation system including prioritisation programmes for highly sensitised patients.
misbadi 150 mg kapseli, kova
towa pharmaceutical europe s.l. - dabigatran etexilate mesilate - kapseli, kova - 150 mg - dabigatraanieteksilaatti
misbadi 110 mg kapseli, kova
towa pharmaceutical europe s.l. - dabigatran etexilate mesilate - kapseli, kova - 110 mg - dabigatraanieteksilaatti
misbadi 75 mg kapseli, kova
towa pharmaceutical europe s.l. - dabigatran etexilate mesilate - kapseli, kova - 75 mg - dabigatraanieteksilaatti